These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 20559997)
21. Hypertrophic cardiomyopathy at 50. Yacoub M; Olivotto I; Cecchi F J Cardiovasc Transl Res; 2009 Dec; 2(4):339-40. PubMed ID: 20559992 [No Abstract] [Full Text] [Related]
22. A novel missense mutation in the myosin binding protein-C gene is responsible for hypertrophic cardiomyopathy with left ventricular dysfunction and dilation in elderly patients. Konno T; Shimizu M; Ino H; Matsuyama T; Yamaguchi M; Terai H; Hayashi K; Mabuchi T; Kiyama M; Sakata K; Hayashi T; Inoue M; Kaneda T; Mabuchi H J Am Coll Cardiol; 2003 Mar; 41(5):781-6. PubMed ID: 12628722 [TBL] [Abstract][Full Text] [Related]
23. Prevalence of hypertrophic cardiomyopathy in highly trained athletes: relevance to pre-participation screening. Basavarajaiah S; Wilson M; Whyte G; Shah A; McKenna W; Sharma S J Am Coll Cardiol; 2008 Mar; 51(10):1033-9. PubMed ID: 18325444 [TBL] [Abstract][Full Text] [Related]
24. [Hypertrophic cardiomyopathy: a genetically-carried heart disease]. van Dockum WG; Doevendans PA; van Rossum AC; Wilde AA Ned Tijdschr Geneeskd; 2002 Apr; 146(15):705-12. PubMed ID: 11980370 [TBL] [Abstract][Full Text] [Related]
25. Clinical profile of hypertrophic cardiomyopathy identified de novo in rural communities. Maron BJ; Mathenge R; Casey SA; Poliac LC; Longe TF J Am Coll Cardiol; 1999 May; 33(6):1590-5. PubMed ID: 10334429 [TBL] [Abstract][Full Text] [Related]
26. When the heart in trouble is a young one. Dulak SB RN; 2006 May; 69(5):24ac1-5; quiz 24ac6. PubMed ID: 16722262 [No Abstract] [Full Text] [Related]
27. Electrocardiographic changes and long-term prognosis of children diagnosed with hypertrophic cardiomyopathy by the school screening program for heart disease in Japan. Morimoto Y; Miyazaki A; Tsuda E; Hayama Y; Negishi J; Ohuchi H J Cardiol; 2020 May; 75(5):571-577. PubMed ID: 31836272 [TBL] [Abstract][Full Text] [Related]
28. Yield of Clinical Screening for Hypertrophic Cardiomyopathy in Child First-Degree Relatives. Norrish G; Jager J; Field E; Quinn E; Fell H; Lord E; Cicerchia MN; Ochoa JP; Cervi E; Elliott PM; Kaski JP Circulation; 2019 Jul; 140(3):184-192. PubMed ID: 31006259 [TBL] [Abstract][Full Text] [Related]
30. A cost-effectiveness model of genetic testing for the evaluation of families with hypertrophic cardiomyopathy. Ingles J; McGaughran J; Scuffham PA; Atherton J; Semsarian C Heart; 2012 Apr; 98(8):625-30. PubMed ID: 22128210 [TBL] [Abstract][Full Text] [Related]
31. New perspectives on the prevalence of hypertrophic cardiomyopathy. Semsarian C; Ingles J; Maron MS; Maron BJ J Am Coll Cardiol; 2015 Mar; 65(12):1249-1254. PubMed ID: 25814232 [TBL] [Abstract][Full Text] [Related]
32. Multidisciplinary evaluation and management of obstructive hypertrophic cardiomyopathy in 2020: Towards the HCM Heart Team. Pelliccia F; Alfieri O; Calabrò P; Cecchi F; Ferrazzi P; Gragnano F; Kaski JP; Limongelli G; Maron M; Rapezzi C; Seggewiss H; Yacoub MH; Olivotto I Int J Cardiol; 2020 Apr; 304():86-92. PubMed ID: 31983465 [TBL] [Abstract][Full Text] [Related]
34. Pilot study analyzing automated ECG screening of hypertrophic cardiomyopathy. Campbell MJ; Zhou X; Han C; Abrishami H; Webster G; Miyake CY; Sower CT; Anderson JB; Knilans TK; Czosek RJ Heart Rhythm; 2017 Jun; 14(6):848-852. PubMed ID: 28193509 [TBL] [Abstract][Full Text] [Related]
35. Can an athlete have too much ticker? Hypertrophic cardiomyopathy in young athletes. Fitzgerald NM; Sherwood M; Fitzgerald DA J Paediatr Child Health; 2012 Oct; 48(10):E156-60. PubMed ID: 22846097 [TBL] [Abstract][Full Text] [Related]
36. Prevalence, clinical significance, and genetic basis of hypertrophic cardiomyopathy with restrictive phenotype. Kubo T; Gimeno JR; Bahl A; Steffensen U; Steffensen M; Osman E; Thaman R; Mogensen J; Elliott PM; Doi Y; McKenna WJ J Am Coll Cardiol; 2007 Jun; 49(25):2419-26. PubMed ID: 17599605 [TBL] [Abstract][Full Text] [Related]
37. Hypertrophic cardiomyopathy in the adolescent. Ellims AH Aust Fam Physician; 2017; 46(8):553-557. PubMed ID: 28787553 [TBL] [Abstract][Full Text] [Related]
38. Family communication in a population at risk for hypertrophic cardiomyopathy. Batte B; Sheldon JP; Arscott P; Huismann DJ; Salberg L; Day SM; Yashar BM J Genet Couns; 2015 Apr; 24(2):336-48. PubMed ID: 25304619 [TBL] [Abstract][Full Text] [Related]
39. Clinical Course and Quality of Life in High-Risk Patients With Hypertrophic Cardiomyopathy and Implantable Cardioverter-Defibrillators. Maron BJ; Casey SA; Olivotto I; Sherrid MV; Semsarian C; Autore C; Ahmed A; Boriani G; Francia P; Winters SL; Giudici M; Koulova A; Garberich R; Rowin EJ; Sears SF; Maron MS; Spirito P Circ Arrhythm Electrophysiol; 2018 Apr; 11(4):e005820. PubMed ID: 29625970 [TBL] [Abstract][Full Text] [Related]
40. Merits and pitfalls of genetic testing in a hypertrophic cardiomyopathy clinic. Arad M; Monserrat L; Haron-Khun S; Seidman JG; Seidman CE; Arbustini E; Glikson M; Freimark D Isr Med Assoc J; 2014 Nov; 16(11):707-13. PubMed ID: 25558701 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]